Literature DB >> 10222048

Chondroitin-4-sulfate protects high-density lipoprotein against copper-dependent oxidation.

R Albertini1, G De Luca, A Passi, R Moratti, P M Abuja.   

Abstract

We investigated the effect of chondroitinsulphate (CS), the major glycosaminoglycan of the arterial wall, on the oxidation of human high-density lipoprotein (HDL) by kinetic analysis. Chondroitin-4-sulfate (C4S) increased the lag time and reduced the maximum rate of HDL oxidation induced by Cu2+, as assessed by monitoring both conjugated diene formation and low-level chemiluminescence. On the contrary, chondroitin-6-sulfate (C6S) was ineffective. Dermatansulfate exhibited an inhibitory effect comparable to that of C4S. C4S protected also the protein moiety of HDL, as it reduced tryptophan destruction by lipid-oxidizing species and delayed the formation of fluorescent adducts between end products of lipid peroxidation and amino acid residues. Again, C6S was ineffective. C4S was able to bind Cu2+; this resulted in less Cu2+ available for HDL oxidation and likely represented the mechanism of the protective effect. Neither C4S nor C6S affected HDL oxidation by peroxyl radicals, indicating that free radical scavenging activity was not involved in the protective effect. These results suggest that C4S might prevent the oxidative modification of HDL in arterial wall, thus preserving its antiatherogenic potential for reverse cholesterol transport and, possibly, for clearance of oxidized lipids. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10222048     DOI: 10.1006/abbi.1999.1150

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Chondroitin 4-O-Sulfotransferase Is Indispensable for Sulfation of Chondroitin and Plays an Important Role in Maintaining Normal Life Span and Oxidative Stress Responses in Nematodes.

Authors:  Tomomi Izumikawa; Katsufumi Dejima; Yukiko Watamoto; Kazuko H Nomura; Nanako Kanaki; Marika Rikitake; Mai Tou; Daisuke Murata; Eri Yanagita; Ai Kano; Shohei Mitani; Kazuya Nomura; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2016-09-19       Impact factor: 5.157

2.  Alleviation of cell damage in experimental ANP in rats by administration of chondroitin-sulfate reduces.

Authors:  Zhongye He; Renxuan Guo; Chengyao Xie; Nan Liu; Yang Li; Wen Song
Journal:  Front Med China       Date:  2007-02

3.  Chondroitin Lyase from a Marine Arthrobacter sp. MAT3885 for the Production of Chondroitin Sulfate Disaccharides.

Authors:  Varsha Kale; Ólafur Friðjónsson; Jón Óskar Jónsson; Hörður G Kristinsson; Sesselja Ómarsdóttir; Guðmundur Ó Hreggviðsson
Journal:  Mar Biotechnol (NY)       Date:  2015-04-28       Impact factor: 3.619

4.  Glycosaminoglycans reduce oxidative damage induced by copper (Cu+2), iron (Fe+2) and hydrogen peroxide (H2O2) in human fibroblast cultures.

Authors:  Giuseppe M Campo; Angela D'Ascola; Angela Avenoso; Salvatore Campo; Alida M Ferlazzo; Carmelo Micali; Laura Zanghì; Alberto Calatroni
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

5.  Association between Human Plasma Chondroitin Sulfate Isomers and Carotid Atherosclerotic Plaques.

Authors:  Elisabetta Zinellu; Antonio Junior Lepedda; Antonio Cigliano; Salvatore Pisanu; Angelo Zinellu; Ciriaco Carru; Pietro Paolo Bacciu; Franco Piredda; Anna Guarino; Rita Spirito; Marilena Formato
Journal:  Biochem Res Int       Date:  2011-12-15

6.  Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats.

Authors:  Giuseppe M Campo; Angela Avenoso; Salvatore Campo; Alida M Ferlazzo; Domenica Altavilla; Alberto Calatroni
Journal:  Arthritis Res Ther       Date:  2003-03-06       Impact factor: 5.156

7.  Glycosaminoglycans from Co-Products of «Scyliorhinus canicula»: Extraction and Purification in Reference to the European Pharmacopoeia Requirement.

Authors:  Nawras Talmoudi; Noureddine Ghariani; Saloua Sadok
Journal:  Biol Proced Online       Date:  2020-01-02       Impact factor: 3.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.